ClinicalTrials.govpublic full text
Trial of Cabozantinib Plus Atezolizumab in Advanced and Progressive Neoplasms of the Endocrine System. The CABATEN Study
neuroendocrine tumor, anaplastic thyroid cancer, adenocarcinoma, pheochromocytoma, paraganglioma, cabozantinib, atezolizumab, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 807533
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.